Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Accelerated Approval of New TKI Use in CML Sparks Questions
US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) has raised questions due to the number of medications already available for this condition. In October, the US Food and…
English